Perritt Capital Management Inc Chembio Diagnostics, Inc. Transaction History

Perritt Capital Management Inc

  • $185 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$2.88 - $5.64 $88,274 - $172,871
-30,651 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$4.11 - $7.51 $87,333 - $159,579
-21,249 Reduced 40.94%
30,651 $146,000
Q3 2020

Nov 16, 2020
BUY
$3.28 - $5.93 $6,560 - $11,860
2,000 Added 4.01%
51,900 $252,000
Q2 2020

Aug 13, 2020
BUY
$3.18 - $15.54 $158,682 - $775,446
49,900 New
49,900 $162,000

About CHEMBIO DIAGNOSTICS, INC.

CEMI Quotes by TradingView
  • Ticker CEMI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,224,600
  • Description
  • Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...
More about CEMI
Track This Portfolio

Track Perritt Capital Management Inc Portfolio

Follow Perritt Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perritt Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perritt Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email